Glycolipid Metabolic Disorders, Metainflammation, Oxidative Stress, and Cardiovascular Diseases: Unraveling Pathways
暂无分享,去创建一个
J. Haber | Katia Portero Sloan | Caio Sérgio Galina Spilla | Karina Torres Pomini | Eliana de Souza Bastos Mazuqueli Pereira | Lance Alan Sloan | S. Barbalho | Enzo Pereira de Lima | Lucas Fornari Laurindo | Renato Cesar Moretti | Marcela Vialogo Marques de Castro | Edgar Baldi | Bruna Fidencio Rahal Ferraz | V. M. C. S. Catharin | Carolina Haber Mellen | Flávia Cristina Castilho Carácio
[1] B. Burla,et al. Plasma and platelet lipidome changes in Fabry disease. , 2024, Clinica chimica acta; international journal of clinical chemistry.
[2] Sulaiman K. Marafie,et al. mTOR: Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process , 2024, International journal of molecular sciences.
[3] Jialin Fan,et al. Nuclear mTOR Signaling Orchestrates Transcriptional Programs Underlying Cellular Growth and Metabolism , 2024, Cells.
[4] E. Dósa,et al. Growth and differentiation factor-15: A link between inflammaging and cardiovascular disease. , 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[5] Nair Anaga,et al. (+)-Catechin mitigates impairment in insulin secretion and beta cell damage in methylglyoxal-induced pancreatic beta cells. , 2024, Molecular biology reports.
[6] Qiang Li,et al. Insulin resistance, combined with health-related lifestyles, psychological traits and adverse cardiometabolic profiles, is associated with cardiovascular diseases: findings from the BHMC study. , 2024, Food & function.
[7] H. Ou,et al. Naringenin Inhibits Acid Sphingomyelinase-Mediated Membrane Raft Clustering to Reduce NADPH Oxidase Activation and Vascular Inflammation. , 2024, Journal of agricultural and food chemistry.
[8] Sarika Gupta,et al. Diabetes: a review of its pathophysiology, and advanced methods of mitigation , 2024, Current medical research and opinion.
[9] Qing Xia,et al. Dimethyl phthalate induced cardiovascular developmental toxicity in zebrafish embryos by regulating MAPK and calcium signaling pathways. , 2024, The Science of the total environment.
[10] En Ma,et al. Resveratrol protects against myocardial ischemic injury in obese mice via activating SIRT3/FOXO3a signaling pathway and restoring redox homeostasis. , 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[11] A. Chabowski,et al. Adipose tissue place of origin and obesity influence sphingolipid signaling pathway in the adipocytes differentiated from ADMSCs isolated from morbidly obese women. , 2024, Biochemical pharmacology.
[12] R. Touyz,et al. Mechanisms of Vascular Inflammation and Potential Therapeutic Targets: A Position Paper From the ESH Working Group on Small Arteries , 2024, Hypertension.
[13] M. Johansson,et al. GLP-1R signaling modulates colonic energy metabolism, goblet cell number and survival in the absence of gut microbiota , 2024, Molecular metabolism.
[14] A. Degasperi,et al. Epigenetic modulators link mitochondrial redox homeostasis to cardiac function in a sex-dependent manner , 2024, Nature communications.
[15] Y. Qiao,et al. Mitochondria-associated endoplasmic reticulum membrane (MAM): a dark horse for diabetic cardiomyopathy treatment , 2024, Cell death discovery.
[16] Mirinthorn Jutanom,et al. Oxidized-LDL Induces Metabolic Dysfunction in Retinal Pigment Epithelial Cells. , 2024, Biological & pharmaceutical bulletin.
[17] A. Palotie,et al. Cardiovascular Significance and Genetics of Epicardial and Pericardial Adiposity. , 2024, JAMA cardiology.
[18] N. Kongruttanachok,et al. GDF-15: a novel biomarker of heart failure predicts short-term and long-term heart-failure rehospitalization and short-term mortality in patients with acute heart failure syndrome , 2024, BMC cardiovascular disorders.
[19] Lipidomics reveals new lipid-based lung adenocarcinoma early diagnosis model , 2024, EMBO molecular medicine.
[20] Julie K. Freed,et al. Rewiring Endothelial Sphingolipid Metabolism to Favor S1P Over Ceramide Protects From Coronary Atherosclerosis , 2024, Circulation research.
[21] Le-Kun Gui,et al. Krüpple-like factors in cardiomyopathy: emerging player and therapeutic opportunities , 2024, Frontiers in cardiovascular medicine.
[22] Y. Son,et al. The role of 27-hydroxycholesterol in meta-inflammation , 2024, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.
[23] H. Teoh,et al. GLP-1 receptor agonists and vascular protection. , 2024, American journal of physiology. Heart and circulatory physiology.
[24] Cong-Cong Ju,et al. Epigenetic modification: A novel insight into diabetic wound healing , 2024, Heliyon.
[25] M. Alraies,et al. Comparative Efficacy and Safety of Mitral Valve Repair Versus Mitral Valve Replacement in Improving Clinical Outcomes in Patients with Rhematic Heart Disease: A High-Value Care Systematic Review and Meta-Analysis. , 2024, Current problems in cardiology.
[26] Suman Dalal,et al. Vagus nerve stimulation alleviates cardiac dysfunction and inflammatory markers during heart failure in rats , 2024, Autonomic Neuroscience.
[27] B. Glancy,et al. Reorganization of mitochondria–organelle interactions during postnatal development in skeletal muscle , 2024, The Journal of physiology.
[28] O. Ogurkova,et al. [Biomarkers of Inflammation in Predicting the Outcomes of Heart Failure of Ischemic Etiology: the Results of Factor Analysis]. , 2024, Kardiologiia.
[29] Junming Ye,et al. How do sphingosine-1-phosphate affect immune cells to resolve inflammation? , 2024, Frontiers in immunology.
[30] C. Chu,et al. The interactions and biological pathways among metabolomics products of patients with coronary heart disease. , 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[31] B. Bagheri,et al. Atherosclerosis and Toll-Like Receptor4 (TLR4), Lectin-Like Oxidized Low-Density Lipoprotein-1 (LOX-1), and Proprotein Convertase Subtilisin/Kexin Type9 (PCSK9) , 2024, Mediators of inflammation.
[32] G. Gallo,et al. Mitochondrial Dysfunction in Heart Failure: From Pathophysiological Mechanisms to Therapeutic Opportunities , 2024, International journal of molecular sciences.
[33] C. Erridge,et al. Toll-like receptor stimulants in processed meats promote lipid accumulation in macrophages and atherosclerosis in Apoe-/- mice. , 2024, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[34] Bo Huang,et al. Hepatic glycogenesis antagonizes lipogenesis by blocking S1P via UDPG , 2024, Science.
[35] A. Lautenbach,et al. Obesity management: sex-specific considerations , 2024, Archives of gynecology and obstetrics.
[36] F. Garcia,et al. Dithiothreitol reduces oxidative stress and necrosis caused by ultraviolet A radiation in L929 fibroblasts. , 2024, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[37] Chao Liu,et al. A pan-PPAR agonist E17241 ameliorates hyperglycemia and diabetic dyslipidemia in KKAy mice via up-regulating ABCA1 in islet, liver, and white adipose tissue. , 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[38] Scott A. Summers,et al. Ceramides are Fuel Gauges on the Drive to Cardiometabolic Disease. , 2024, Physiological reviews.
[39] C. Macchi,et al. Exploring the role of epicardial adipose-tissue-derived extracellular vesicles in cardiovascular diseases , 2024, iScience.
[40] Hui Yao,et al. Downregulation of VEGFA accelerates AGEs-mediated nucleus pulposus degeneration through inhibiting protective mitophagy in high glucose environments. , 2024, International journal of biological macromolecules.
[41] Akiko Sakai-Sakasai,et al. Structures of Toxic Advanced Glycation End-Products Derived from Glyceraldehyde, A Sugar Metabolite , 2024, Biomolecules.
[42] Alexander V. Panov. The Structure of the Cardiac Mitochondria Respirasome Is Adapted for the β-Oxidation of Fatty Acids , 2024, International journal of molecular sciences.
[43] Jianqing Lin,et al. Sphingolipid metabolism controls mammalian heart regeneration. , 2024, Cell metabolism.
[44] V. Olkkonen,et al. Adipocyte-endothelial cell interplay in adipose tissue physiology. , 2024, Biochemical pharmacology.
[45] Huijuan Luo,et al. MiR-375 Inhibitor Alleviates Inflammation and Oxidative Stress by Upregulating the GPR39 Expression in Atherosclerosis. , 2024, International heart journal.
[46] Chong-Zhi Wang,et al. Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis , 2024, BMJ.
[47] Yipu Huang,et al. Fructose aggravates copper-deficiency-induced cardiac remodeling by inhibiting SERCA2a. , 2024, The Journal of pharmacy and pharmacology.
[48] Zichong Song,et al. Ferroptosis: A New Mechanism in Diabetic Cardiomyopathy , 2024, International journal of medical sciences.
[49] I. Gianopoulos,et al. Macrophage profiling in atherosclerosis: understanding the unstable plaque. , 2024, Basic research in cardiology.
[50] Rui Li,et al. ACE2 Regulates Glycolipid Metabolism in Multiple Tissues. , 2024, Frontiers in bioscience.
[51] Qin Zhang,et al. Gut microbiota dysbiosis and decreased levels of acetic and propionic acid participate in glucocorticoid-induced glycolipid metabolism disorder , 2024, mBio.
[52] Yasushi Mukai. Inflammation and atrial fibrillation , 2024, Journal of arrhythmia.
[53] E. Brady,et al. Circulating sphingolipids and relationship to cardiac remodelling before and following a low-energy diet in asymptomatic Type 2 Diabetes , 2024, BMC cardiovascular disorders.
[54] Qi Guo,et al. Myeloid-derived grancalcin instigates obesity-induced insulin resistance and metabolic inflammation in male mice , 2024, Nature communications.
[55] I. Mori,et al. Sphingosine 1-Phosphate Regulates Obesity and Glucose Homeostasis , 2024, International journal of molecular sciences.
[56] Juan S Peña,et al. Neurovascular Relationships in AGEs-Based Models of Proliferative Diabetic Retinopathy , 2024, Bioengineering.
[57] Ali Attiq,et al. Hegemony of inflammation in atherosclerosis and coronary artery disease. , 2024, European journal of pharmacology.
[58] Sharif hasan Siddiqui,et al. Acute Intake of Fructose Increases Arterial Pressure in Humans: A Meta-Analysis and Systematic Review , 2024, Nutrients.
[59] C. Indolfi,et al. Pathophysiology of Atrial Fibrillation and Approach to Therapy in Subjects Less than 60 Years Old , 2024, International journal of molecular sciences.
[60] Jiawei Zheng,et al. Inhibition of Hyperglycemia and Hyperlipidemia by Blocking Toll-like Receptor 4: Comparison of Wild-Type and Toll-like Receptor 4 Gene Knockout Mice on Obesity and Diabetes Modeling , 2024, Biology.
[61] S. Rovira-Llopis,et al. Cardiovascular benefits of SGLT2 inhibitors and GLP-1 receptor agonists through effects on mitochondrial function and oxidative stress. , 2024, Free radical biology & medicine.
[62] Brian C. Case,et al. Targeting inflammation in atherosclerosis: overview, strategy and directions. , 2024, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[63] Yujun Jiang,et al. Lactobacillus paracasei JY062 Alleviates Glucolipid Metabolism Disorders via the Adipoinsular Axis and Gut Microbiota , 2024, Nutrients.
[64] J. Terrand,et al. Cholesterol Trafficking, Lysosomal Function and Atherosclerosis. , 2023, American journal of physiology. Cell physiology.
[65] Yun Ling,et al. Dysregulation of Ceramide Metabolism Is Linked to Iron Deposition and Activation of Related Pathways in the Aorta of Atherosclerotic Miniature Pigs , 2023, Antioxidants.
[66] Aijuan Qu,et al. Diabetes Mellitus to Accelerated Atherosclerosis: Shared Cellular and Molecular Mechanisms in Glucose and Lipid Metabolism. , 2023, Journal of cardiovascular translational research.
[67] P. Nagareddy,et al. Impact of age and sex on myelopoiesis and inflammation during myocardial infarction. , 2023, Journal of molecular and cellular cardiology.
[68] F. Priego-Capote,et al. Comprehensive profiling of ceramides in human serum by liquid chromatography coupled to tandem mass spectrometry combining data independent/dependent acquisition modes. , 2023, Analytica chimica acta.
[69] R. Lataro,et al. Inflammation of some visceral sensory systems and autonomic dysfunction in cardiovascular disease , 2023, Autonomic Neuroscience.
[70] Mohammad S. Mubarak,et al. Reactive oxygen species in biological systems: Pathways, associated diseases, and potential inhibitors—A review , 2023, Food science & nutrition.
[71] Xuan Zhao,et al. Associations Between Serum TNF-α, IL-6, hs-CRP and GLMD in Obese Children and Adolescents: A Cross-Sectional Study , 2023, Diabetes, metabolic syndrome and obesity : targets and therapy.
[72] Julie K. Freed,et al. Necessary Role of Ceramides in the Human Microvascular Endothelium During Health and Disease , 2023, Circulation research.
[73] D. Kapogiannis,et al. Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model , 2023, Translational Neurodegeneration.
[74] B. Bouillet,et al. Screening and management of metabolic complications of mTOR inhibitors in real-life settings. , 2023, Annales d'endocrinologie.
[75] M. Sarzynski,et al. Effects of exercise training on ANGPTL3/8 and ANGPTL4/8 and their associations with cardiometabolic traits , 2023, Journal of lipid research.
[76] Yatao Huang,et al. Stereoselective cardiotoxic effects of metconazole on zebrafish (Danio rerio) based on AGE-RAGE signalling pathway. , 2023, The Science of the total environment.
[77] Zheng Shen,et al. Nutrient-sensing growth hormone secretagogue receptor in macrophage programming and meta-inflammation , 2023, Molecular metabolism.
[78] Deshi Dong,et al. Vanin1 (VNN1) in chronic diseases: Future directions for targeted therapy. , 2023, European journal of pharmacology.
[79] Ziyan Zhao,et al. Ganglioside GM3 Protects Against Abdominal Aortic Aneurysm by Suppressing Ferroptosis , 2023, Circulation.
[80] María del Pilar Ramos-Godínez,et al. Immunolocalization of Sphingolipid Catabolism Enzymes along the Nephron: Novel Early Urinary Biomarkers of Renal Damage , 2023, International journal of molecular sciences.
[81] V. Pesce,et al. Different Effects of High-Fat/High-Sucrose and High-Fructose Diets on Advanced Glycation End-Product Accumulation and on Mitochondrial Involvement in Heart and Skeletal Muscle in Mice , 2023, Nutrients.
[82] R. Virmani,et al. Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies , 2023, Arteriosclerosis, thrombosis, and vascular biology.
[83] B. Nordestgaard,et al. Remnant cholesterol and low-grade inflammation jointly in atherosclerotic cardiovascular disease: implications for clinical trials , 2023, Current opinion in clinical nutrition and metabolic care.
[84] C. P. Dos Santos,et al. Parental fructose consumption induces early baroreflex dysfunction in offspring: impact on arterial pressure and on insulin resistance , 2023, International journal of obesity.
[85] X. Puéchal,et al. Dysregulation of neutrophil oxidant production and interleukin-1-related cytokines in granulomatosis with polyangiitis. , 2023, Rheumatology.
[86] Lele Feng,et al. Epicardial adipose tissue, metabolic disorders, and cardiovascular diseases: recent advances classified by research methodologies , 2023, MedComm.
[87] A. Banerjee,et al. Fatty Acids and their Proteins in Adipose Tissue Inflammation , 2023, Cell biochemistry and biophysics.
[88] Zheng‐Da Pang,et al. Nogo-B mediates endothelial oxidative stress and inflammation to promote coronary atherosclerosis in pressure-overloaded mouse hearts , 2023, Redox biology.
[89] Gowri Palanissami,et al. AGEs and RAGE: metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancers , 2023, Exploration of targeted anti-tumor therapy.
[90] K. Gutbrod,et al. Analysis of circulating ceramides and hexosylceramides in patients with coronary artery disease and type II diabetes mellitus , 2023, BMC Cardiovascular Disorders.
[91] B. Wasita,et al. Effect of Dapagliflozin on Patients with Rheumatic Heart Disease Mitral Stenosis , 2023, Journal of clinical medicine.
[92] Anindita Das,et al. mTOR Signaling: New Insights into Cancer, Cardiovascular Diseases, Diabetes and Aging , 2023, International journal of molecular sciences.
[93] M. U. Khan,et al. Natural Allies for Heart Health: Nrf2 Activation and Cardiovascular Disease Management. , 2023, Current problems in cardiology.
[94] Shi-you Chen,et al. Vagus nerve stimulation‐induced stromal cell‐derived factor‐l alpha participates in angiogenesis and repair of infarcted hearts , 2023, ESC heart failure.
[95] K. Kuča,et al. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging , 2023, Archives of Toxicology.
[96] P. Libby,et al. Inflammation in acute myocardial infarction: the good, the bad and the ugly , 2023, European heart journal.
[97] Fuquan Wang,et al. Toll-like receptor 4: A potential therapeutic target for multiple human diseases. , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[98] Lawrence A Leiter,et al. Fructose-containing food sources and blood pressure: A systematic review and meta-analysis of controlled feeding trials , 2023, PloS one.
[99] P. Mailloux-Salinas,et al. Combined fructose and sucrose consumption from an early age aggravates cardiac oxidative damage and causes a dilated cardiomyopathy in SHR rats , 2023, Journal of clinical biochemistry and nutrition.
[100] Suo Xu,et al. Regulation of toll-like receptor (TLR) signaling pathways in atherosclerosis: from mechanisms to targeted therapeutics , 2023, Acta Pharmacologica Sinica.
[101] Yinghan Shi,et al. VNN1 as a potential biomarker for sepsis diagnosis and its implications in immune infiltration and tumor prognosis , 2023, Frontiers in medicine.
[102] Li-ting Zhou,et al. The effects of brominated flame retardants (BFRs) on pro-atherosclerosis mechanisms. , 2023, Ecotoxicology and environmental safety.
[103] S. Bhadada,et al. AGEs accumulation with vascular complications, glycemic control and metabolic syndrome: A narrative review. , 2023, Bone.
[104] S. Sideris,et al. Angiotensin Regulation of Vascular Homeostasis: Exploring the Role of ROS and RAS Blockers , 2023, International journal of molecular sciences.
[105] A. Paziewska,et al. The Ketogenic Diet and Cardiovascular Diseases , 2023, Nutrients.
[106] F. Stentz,et al. Ceramides and other sphingolipids as predictors of incident dysglycemia (CASPID): Design, methods, and baseline characteristics , 2023, Experimental biology and medicine.
[107] Shu Li,et al. Bisphenol A Regulates the TNFR1 Pathway and Excessive ROS Mediated by miR-26a-5p/ADAM17 Axis to Aggravate Selenium Deficiency-Induced Necroptosis in Broiler Veins , 2023, Biological trace element research.
[108] K. Czajkowski,et al. Receptor for the Advanced Glycation End Products (RAGE) Pathway in Adipose Tissue Metabolism , 2023, International journal of molecular sciences.
[109] Tian Tian,et al. mTOR Signaling Pathway and Gut Microbiota in Various Disorders: Mechanisms and Potential Drugs in Pharmacotherapy , 2023, International journal of molecular sciences.
[110] S. Sharma,et al. Inhibition of Pyruvate kinase M2 (PKM2) by shikonin attenuates isoproterenol-induced acute myocardial infarction via reduction in inflammation, hypoxia, apoptosis, and fibrosis , 2023, Naunyn-Schmiedeberg's archives of pharmacology.
[111] H. Tomiyama. Vascular function: a key player in hypertension , 2023, Hypertension Research.
[112] O. Zimba,et al. Cardiovascular issues in rheumatic diseases , 2023, Clinical Rheumatology.
[113] R. de Caterina,et al. NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis. , 2023, Cardiovascular research.
[114] H. Tilg,et al. An international multidisciplinary consensus statement on MAFLD and the risk of CVD , 2023, Hepatology International.
[115] H. Riezman,et al. Lipid metabolism around the body clocks. , 2023, Progress in lipid research.
[116] A. Severino,et al. Meta-Inflammation and New Anti-Diabetic Drugs: A New Chance to Knock Down Residual Cardiovascular Risk , 2023, International journal of molecular sciences.
[117] D. Tousoulis,et al. Epicardial adipose tissue in myocardial disease: from physiology to heart failure phenotypes. , 2023, Current problems in cardiology.
[118] Wenyi Wei,et al. Inactivation of Minar2 in mice hyperactivates mTOR signaling and results in obesity , 2023, Molecular metabolism.
[119] Muxing Kang,et al. VNN1 overexpression in pancreatic cancer cells inhibits paraneoplastic islet function by increasing oxidative stress and inducing β‑cell dedifferentiation , 2023, Oncology reports.
[120] Annet Kirabo,et al. Mechanisms of Oxidative Stress in Metabolic Syndrome , 2023, International journal of molecular sciences.
[121] M. Madhur,et al. Inflammation Resolution in the Cardiovascular System: Arterial Hypertension, Atherosclerosis, and Ischemic Heart Disease. , 2023, Antioxidants & redox signaling.
[122] Jingfang Liu,et al. Ferroptosis: roles and molecular mechanisms in diabetic cardiomyopathy , 2023, Frontiers in Endocrinology.
[123] Y. Chen,et al. Growth differentiation factor-15/adiponectin ratio as a potential biomarker for metabolic syndrome in Han Chinese , 2023, Frontiers in Endocrinology.
[124] P. Calder,et al. Anthocyanins ameliorate obesity-associated metainflammation: Preclinical and clinical evidence. , 2023, Nutrition research.
[125] G. Aroca-Martínez,et al. Novel Biomarkers of Diabetic Kidney Disease , 2023, Biomolecules.
[126] M. Mayr,et al. Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction , 2023, European heart journal.
[127] D. Agrawal,et al. Role of sirtuins in attenuating plaque vulnerability in atherosclerosis , 2023, Molecular and cellular biochemistry.
[128] Fan Zhang,et al. Metaflammation in glucolipid metabolic disorders: Pathogenesis and treatment. , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[129] A. Belfiore,et al. Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy , 2023, Endocrine reviews.
[130] Zhongzhou Guo,et al. Proline/serine‐rich coiled‐coil protein 1 inhibits macrophage inflammation and delays atherosclerotic progression by binding to Annexin A2 , 2023, Clinical and translational medicine.
[131] Jianping Ma,et al. Total sugar, added sugar, fructose, and sucrose intake and all-cause, cardiovascular, and cancer mortality: A systematic review and dose-response meta-analysis of prospective cohort studies. , 2023, Nutrition.
[132] J. Frampton. Inclisiran: A Review in Hypercholesterolemia , 2023, American Journal of Cardiovascular Drugs.
[133] J. Goldberger,et al. Human Epicardial Adipose Tissue Expresses Glucose-dependent Insulinotropic Polypeptide, Glucagon and Glucagon-Like Peptide 1 Receptors as Potential Targets of Pleiotropic Therapies. , 2023, European journal of preventive cardiology.
[134] D. Atar,et al. Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE , 2023, Circulation.
[135] Stephen J. Nicholls. PCSK9 inhibitors and reduction in cardiovascular events: Current evidence and future perspectives. , 2023, Kardiologia polska.
[136] C. Kendall,et al. The Effect of Non-Nutritive Sweetened Beverages on Postprandial Glycemic and Endocrine Responses: A Systematic Review and Network Meta-Analysis , 2023, Nutrients.
[137] L. Rallidis,et al. Emerging markers of inflammation and oxidative stress as potential predictors of coronary artery disease. , 2023, International journal of cardiology.
[138] D. Tousoulis,et al. Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment , 2023, Molecules.
[139] N. Mehta,et al. Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: A systematic review and meta-analysis , 2023, Frontiers in Cardiovascular Medicine.
[140] Zenglei Zhang,et al. Role of inflammation, immunity, and oxidative stress in hypertension: New insights and potential therapeutic targets , 2023, Frontiers in Immunology.
[141] M. Ciccarelli,et al. The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers , 2023, Biomolecules.
[142] Xueyuan Yang,et al. Epicardial Adipose Tissue and Diabetic Cardiomyopathy , 2023, Journal of cardiovascular pharmacology and therapeutics.
[143] P. Duell. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease Risk. , 2023, Journal of the American College of Cardiology.
[144] Hun‐Sung Kim,et al. Long-Term Risk of Cardiovascular Disease Among Type 2 Diabetes Patients According to Average and Visit-to-Visit Variations of HbA1c Levels During the First 3 Years of Diabetes Diagnosis , 2022, Journal of Korean medical science.
[145] Ewa Rusak,et al. Atherosclerosis: risk assessment and the role of aiming for optimal glycaemic control in young patients with type 1 diabetes , 2022, Pediatric endocrinology, diabetes, and metabolism.
[146] F. Crea,et al. GLUT-1/PKM2 loop dysregulation in patients with non-ST-segment elevation myocardial infarction promotes metainflammation. , 2022, Cardiovascular research.
[147] Guibo Sun,et al. Role of Adiponectin in Cardiovascular Diseases Related to Glucose and Lipid Metabolism Disorders , 2022, International journal of molecular sciences.
[148] Yabing Zhang,et al. The Relationship Between Major Food Sources of Fructose and Cardiovascular Outcomes: A Systematic Review and Dose-Response Meta-Analysis of Prospective Studies , 2022, Advances in nutrition.
[149] S. Chatterjee,et al. Glycosphingolipids in Diabetes, Oxidative Stress, and Cardiovascular Disease: Prevention in Experimental Animal Models , 2022, International journal of molecular sciences.
[150] Beata Franczyk,et al. The Role of Inflammation and Oxidative Stress in Rheumatic Heart Disease , 2022, International journal of molecular sciences.
[151] J Zhang,et al. Associations among carotid plaque progression, cerebrovascular/cardiovascular diseases and LDL-C/non-HDL-C goal achievement in diabetic patients: A retrospective cohort study. , 2022, Journal of diabetes and its complications.
[152] M. Sevick,et al. The RAGE/DIAPH1 axis: mediator of obesity and proposed biomarker of human cardiometabolic disease. , 2022, Cardiovascular research.
[153] M. Bennett,et al. The Role of Oxidative Stress in Atherosclerosis , 2022, Cells.
[154] D. Gómez-Coronado,et al. Macrophage-Derived 25-Hydroxycholesterol Promotes Vascular Inflammation, Atherogenesis, and Lesion Remodeling , 2022, Circulation.
[155] S. Pan,et al. Cardiovascular Manifestations in Rheumatoid Arthritis , 2022, Cardiology in review.
[156] Beiyan Zhou,et al. Macrophages at the Crossroad of Meta-Inflammation and Inflammaging , 2022, Genes.
[157] R. Laaksonen,et al. Ceramides and Phosphatidylcholines Associate with Cardiovascular Diseases in the Elderly. , 2022, Clinical chemistry.
[158] Faheem,et al. Fathoming the role of mTOR in diabetes mellitus and its complications. , 2022, Current molecular pharmacology.
[159] Qi Chen,et al. Angiotensin-converting enzyme 2 improves hepatic insulin resistance by regulating GABAergic signaling in the liver , 2022, The Journal of biological chemistry.
[160] Yanqiao Zhang,et al. Activating transcription factor 3, glucolipid metabolism, and metabolic diseases , 2022, Journal of molecular cell biology.
[161] Lawrence A Leiter,et al. Effect of Important Food Sources of Fructose-Containing Sugars on Inflammatory Biomarkers: A Systematic Review and Meta-Analysis of Controlled Feeding Trials , 2022, Nutrients.
[162] Peifeng Li,et al. The mechanisms of glycolipid metabolism disorder on vascular injury in type 2 diabetes , 2022, Frontiers in Physiology.
[163] Lang Li,et al. Inflammation and Oxidative Stress Role of S100A12 as a Potential Diagnostic and Therapeutic Biomarker in Acute Myocardial Infarction , 2022, Oxidative medicine and cellular longevity.
[164] M. Shariq,et al. Aftermath of AGE-RAGE Cascade in the pathophysiology of cardiovascular ailments. , 2022, Life sciences.
[165] A. Hingorani,et al. Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease: A Factorial Mendelian Randomization Study. , 2022, JAMA cardiology.
[166] R. Goulart,et al. The Effects of Probiotics, Prebiotics and Synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review , 2022, International journal of molecular sciences.
[167] P. Whitfield,et al. Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR−/− mice , 2022, bioRxiv.
[168] A. Donato,et al. Mechanisms and consequences of endothelial cell senescence , 2022, Nature Reviews Cardiology.
[169] M. Takeuchi,et al. Effects of Toxic AGEs (TAGE) on Human Health , 2022, Cells.
[170] A. Franco-Obregón,et al. Magnetic field therapy enhances muscle mitochondrial bioenergetics and attenuates systemic ceramide levels following ACL reconstruction: Southeast Asian randomized-controlled pilot trial , 2022, Journal of orthopaedic translation.
[171] Lawrence A Leiter,et al. Important Food Sources of Fructose-Containing Sugars and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Controlled Trials , 2022, Nutrients.
[172] A. Flouris,et al. The impact of adipokines on vascular networks in adipose tissue. , 2022, Cytokine & growth factor reviews.
[173] B. Lakkakula,et al. Biomarkers of Oxidative Stress Tethered to Cardiovascular Diseases , 2022, Oxidative medicine and cellular longevity.
[174] Chang Liu,et al. Investigation of Statin Medication Use in Elderly Patients with Cardiovascular Disease on Regular Physical Examination and the Relationship with Glucolipid Metabolism and Adverse Cardiovascular Prognosis , 2022, Disease markers.
[175] Xingmin Li,et al. Alteration of Mitochondrial Lipidome and Its Potential Effect on Apoptosis, Mitochondrial Reactive Oxygen Species Production, and Muscle Oxidation in Beef during Early Postmortem. , 2022, Journal of agricultural and food chemistry.
[176] Lun Xiao,et al. The Determinants of Adolescent Glycolipid Metabolism Disorder: A Cohort Study , 2022, International journal of endocrinology.
[177] G. Czarnota,et al. Involvement of Ceramide Signalling in Radiation-Induced Tumour Vascular Effects and Vascular-Targeted Therapy , 2022, International journal of molecular sciences.
[178] M. Kals,et al. Markers of Inflammation, Oxidative Stress, and Fibrosis in Patients with Atrial Fibrillation , 2022, Oxidative medicine and cellular longevity.
[179] Yuchen Tang,et al. A Meta-Analysis of High-Intensity Interval Training on Glycolipid Metabolism in Children With Metabolic Disorders , 2022, Frontiers in Pediatrics.
[180] B. Crespo-Facorro,et al. Metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: 3 years follow-up results from the PAFIP cohort. , 2022, Spanish journal of psychiatry and mental health.
[181] Ł. Bułdak. Cardiovascular Diseases—A Focus on Atherosclerosis, Its Prophylaxis, Complications and Recent Advancements in Therapies , 2022, International journal of molecular sciences.
[182] A. Twarda-Clapa,et al. Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs , 2022, Cells.
[183] A. Adem,et al. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives , 2022, Biomolecules.
[184] P. Holvoet,et al. Oxidative Stress and Inflammation in Cardiovascular Diseases and Cancer: Role of Non-coding RNAs , 2022, The Yale journal of biology and medicine.
[185] Shi Qi Li,et al. Changes of circulating biomarkers of inflammation and glycolipid metabolism by CPAP in OSA patients: a meta-analysis of time-dependent profiles , 2022, Therapeutic advances in chronic disease.
[186] U. P. Flato,et al. Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future , 2022, International journal of molecular sciences.
[187] Daniel de Bortoli Teixeira,et al. GLP-1a: Going beyond Traditional Use , 2022, International journal of molecular sciences.
[188] X. Xia,et al. GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[189] Hai-Jian Sun,et al. A narrative review of plant and herbal medicines for delaying diabetic atherosclerosis: an update and future perspectives. , 2021, Reviews in cardiovascular medicine.
[190] K. Krüger,et al. Type and Intensity as Key Variable of Exercise in Metainflammation diseases: A Review , 2021, International Journal of Sports Medicine.
[191] R. Sah,et al. Links between ceramides and cardiac function , 2021, Current opinion in lipidology.
[192] A. Jayedi,et al. The relationship between major food sources of fructose and cardiovascular disease, cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of cohort studies , 2021, Critical reviews in food science and nutrition.
[193] S. Emamgholipour,et al. Polyphenols: Potential anti‐inflammatory agents for treatment of metabolic disorders , 2021, Phytotherapy research : PTR.
[194] M. Kwiatkowski,et al. Meta-Inflammation and Metabolic Reprogramming of Macrophages in Diabetes and Obesity: The Importance of Metabolites , 2021, Frontiers in Immunology.
[195] J. Bissler,et al. Leptin receptor defect with diabetes causes skeletal muscle atrophy in female obese Zucker rats where peculiar depots networked with mitochondrial damages , 2021, Ultrastructural pathology.
[196] M. Bechara,et al. Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors , 2021, Diabetes/metabolism research and reviews.
[197] A. Girotti,et al. Pathophysiological potential of lipid hydroperoxide intermembrane translocation: Cholesterol hydroperoxide translocation as a special case , 2021, Redox biology.
[198] F. Rodríguez‐Artalejo,et al. Metabolic syndrome and Growth Differentiation Factor 15 in older adults , 2021, GeroScience.
[199] Xin Liu,et al. Distinct metabonomic signatures of Polygoni Multiflori Radix Praeparata against glucolipid metabolic disorders. , 2021, The Journal of pharmacy and pharmacology.
[200] Ariel D. Quiroga,et al. Mitochondria-rough-ER contacts in the liver regulate systemic lipid homeostasis. , 2021, Cell reports.
[201] Joseph A. Hill,et al. Cardiometabolic disease: Mechanisms to therapies. , 2021, Journal of molecular and cellular cardiology.
[202] U. P. Flato,et al. Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions , 2021, International journal of molecular sciences.
[203] K. Prasad. AGE–RAGE Stress and Coronary Artery Disease , 2021, International Journal of Angiology.
[204] Yanduan Lin,et al. Hypothalamus-pituitary-adrenal Axis in Glucolipid metabolic disorders , 2020, Reviews in Endocrine and Metabolic Disorders.
[205] N. Esmaeil,et al. Meta-inflammatory state and insulin resistance can improve after 10 weeks of combined all-extremity high-intensity interval training in sedentary overweight/obese females: a quasi-experimental study , 2020, Journal of Diabetes & Metabolic Disorders.
[206] Joseph A. Hill,et al. Metabolic Inflammation in Heart Failure with Preserved Ejection Fraction. , 2020, Cardiovascular research.
[207] A. Goldberg,et al. Alterations in plasma triglycerides and ceramides: links with cardiac function in humans with type 2 diabetes , 2020, Journal of Lipid Research.
[208] F. Parveen,et al. Role of Ceramidases in Sphingolipid Metabolism and Human Diseases , 2019, Cells.
[209] J. H. Kim,et al. High-Sensitivity C-Reactive Protein Is Associated with Prediabetes and Adiposity in Korean Youth. , 2019, Metabolic syndrome and related disorders.
[210] L. Obeid,et al. Molecular mechanisms of regulation of sphingosine kinase 1. , 2018, Biochimica et biophysica acta. Molecular and cell biology of lipids.
[211] P. Hopkins,et al. Skeletal muscle ceramides and relationship with insulin sensitivity after 2 weeks of simulated sedentary behaviour and recovery in healthy older adults , 2018, The Journal of physiology.
[212] A. Xu,et al. Liver-adipose tissue crosstalk: A key player in the pathogenesis of glucolipid metabolic disease , 2017, Chinese Journal of Integrative Medicine.
[213] Kim Ekroos,et al. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol , 2016, European heart journal.
[214] R. J. Tofano,et al. Metabolic syndrome, atherosclerosis and inflammation: an inseparable triad? , 2015 .
[215] R. DeFronzo,et al. Plasma Ceramides Are Elevated in Obese Subjects With Type 2 Diabetes and Correlate With the Severity of Insulin Resistance , 2009, Diabetes.
[216] T. S. Ramasamy,et al. RNA therapeutics for treatment of diabetes. , 2024, Progress in molecular biology and translational science.
[217] T. Toyomura,et al. [Regulation of inflammatory response based on interaction among AGEs, DAMPs, and/or cytokines]. , 2022, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.